Treating cardiovascular disease in women

Menopause Int. 2007 Dec;13(4):159-64. doi: 10.1258/175404507783004104.

Abstract

Cardiovascular disease (CVD) is the most common cause of death in women but some of the challenges of management differ from those in men. This article addresses the gender-specific issues of cardiovascular management, with emphasis on ischaemic heart disease and modification of coronary risk factors. Women with ischaemic heart disease present later than men, and are therefore older and more likely to suffer from co-morbidities such as diabetes and hypertension. Proven CVD risk factors in women can be divided into those that are modifiable and those that are non-modifiable. The former include diabetes, dyslipidaemia, hypertension, smoking, obesity, sedentary lifestyle and poor nutrition; the latter include family history of heart disease and older age at presentation. It is this difference in age and general health that explains much of the variability in response to treatment. Pharmacotherapy, percutaneous intervention, surgical revascularization, and cardiac rehabilitation and disease prevention are discussed.

Publication types

  • Review

MeSH terms

  • Cardiac Catheterization
  • Cardiovascular Agents / therapeutic use
  • Cardiovascular Diseases / drug therapy
  • Cardiovascular Diseases / epidemiology*
  • Cardiovascular Diseases / surgery
  • Cardiovascular Diseases / therapy*
  • Comorbidity
  • Coronary Artery Bypass
  • Dyslipidemias / epidemiology
  • Female
  • Health Knowledge, Attitudes, Practice
  • Humans
  • Hypertension / epidemiology
  • Life Style
  • Obesity / epidemiology
  • Postmenopause
  • Primary Prevention / organization & administration*
  • Risk Factors
  • Sex Factors
  • Smoking / epidemiology
  • Stress, Psychological / epidemiology
  • United States
  • Women's Health*

Substances

  • Cardiovascular Agents